A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 1, 2013, Pages 109-116

  Karras, Nicole A ^a   Weeres, Matthew ^a   Sessions, Wendy ^b   Xu, Xiyan ^b   DeFor, Todd ^c   Young, Jo Anne H ^a   Stefanski, Heather ^a   Brunstein, Claudio ^a   Cooley, Sarah ^a   Miller, Jeffrey S ^a   Blazar, Bruce R ^a   Wagner, John E ^a   Verneris, Michael R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

BMT; Influenza; UCB transplantation; Vaccine

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; ADVERSE OUTCOME; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG USE; FEMALE; GRAFT VERSUS HOST REACTION; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; TREATMENT OUTCOME; TREATMENT RESPONSE; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; ANTIGENS, CD19; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLUENZA VACCINES; INTERFERON-GAMMA; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84871918768     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.08.015     Document Type: Article

References (33)

1. Fiore A.E., Bridges C.B., Cox N.J. Seasonal influenza vaccines. Curr Top Microbiol Immunol 2009, 333:43-82.
2. Lee I., Barton T.D. Viral respiratory tract infections in transplant patients: epidemiology, recognition and management. Drugs 2007, 67:1411-1427.
3. Ljungman P., Ward K.N., Crooks B.N., et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001, 28:479-484.
4. Martino R., Porras R.P., Rabella N., et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005, 11:781-796.
5. Bowden R.A. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med 1997, 102:27-30. discussion 42-43.
6. Champlin R.E., Whimbey E. Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience. Biol Blood Marrow Transplant 2001, 7(suppl):8S-10S.
7. Whimbey E., Elting L.S., Couch R.B., et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994, 13:437-440.
8. Nichols W.G., Guthrie K.A., Corey L., Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004, 39:1300-1306.
9. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol 2002, 118:44-57.
10. Mohty B., Thomas Y., Vukicevic M., et al. Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT. Bone Marrow Transplant 2012, 47:236-242.
11. Ljungman P. Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant 2001, 7(suppl):5S-7S.
12. Machado C.M., Cardoso M.R., Da Rocha I.F., Boas L.S., Dulley F.L., Pannuti C.S. The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant 2005, 36:897-900.
13. Avetisyan G., Aschan J., Hassan M., Ljungman P. Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation. Transplantation 2008, 86:257-263.
14. Gandhi M.K., Egner W., Sizer L., et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant 2001, 28:775-781.
15. Tomblyn M., Chiller T., Einsele H., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009, 15:1143-1238.
16. Fiore A.E., Bridges C.B., Cox N.J. Seasonal influenza vaccines. Curr Top Microbiol Immunol 2009, 333:43-82. Review. PMID: 19768400 [PubMed - indexed for MEDLINE].
17. Hurwitz E.S., Haber M., Chang A., et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 2000, 182:1218-1221.
18. Block S.L., Toback S.L., Yi T., Ambrose C.S. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years. Clin Ther 2009, 31:2140-2147.
19. Engelhard D., Nagler A., Hardan I., et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993, 11:1-5.
20. WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. 2011. Available at: Accessed: August 30, 2012. http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf.
21. Ljungman P., Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant 2008, 42:637-641.
22. Ljungman P., Cordonnier C., Einsele H., et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009, 44:521-526.
23. De Lavallade H., Garland P., Sekine T., et al. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica 2011, 96:307-314.
24. Cox R.J., Brokstad K.A. The postvaccination antibody response to influenza virus proteins. APMIS 1999, 107:289-296.
25. Honebrink T., Dayton V., Burke M.J., et al. Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia. Biol Blood Marrow Transplant 2012, 18:930-936.
26. Beaudette-Zlatanova B.C., Le P.T., Knight K.L., et al. A potential role for B cells in suppressed immune responses in cord blood transplant recipients. Bone Marrow Transplant 2012, [Epub ahead of print].
27. Mohty B., Bel M., Vukicevic M., et al. Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients. Haematologica 2011, 96:896-904.
28. Pao M., Papadopoulos E.B., Chou J., et al. Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT). Biology of Blood and Marrow Transplantation 2008, 14:1022-1030.
29. Small T.N., Cowan M.J. Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases. Expert Rev Clin Immunol 2011, 7:193-203.
30. Issa N.C., Marty F.M., Gagne L.S., et al. Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2011, 17:434-438.
31. Komanduri K.V., St John L.S., De Lima M., et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007, 110:4543-4551.
32. Kadereit S., Mohammad S.F., Miller R.E., et al. Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood 1999, 94:3101-3107.
33. Kaminski B.A., Kadereit S., Miller R.E., et al. Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation. Blood 2003, 102:4608-4617.